Agilent Technologies Total Long-Term Assets 2010-2025 | A
Agilent Technologies total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
- Agilent Technologies total long-term assets for the quarter ending April 30, 2025 were $7.950B, a 19.49% increase year-over-year.
- Agilent Technologies total long-term assets for 2024 were $7.887B, a 19.92% increase from 2023.
- Agilent Technologies total long-term assets for 2023 were $6.577B, a 2.62% decline from 2022.
- Agilent Technologies total long-term assets for 2022 were $6.754B, a 2.2% decline from 2021.
| Agilent Technologies Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $7,887 |
| 2023 | $6,577 |
| 2022 | $6,754 |
| 2021 | $6,906 |
| 2020 | $6,212 |
| 2019 | $6,263 |
| 2018 | $4,693 |
| 2017 | $4,257 |
| 2016 | $4,159 |
| 2015 | $3,793 |
| 2014 | $5,306 |
| 2013 | $5,703 |
| 2012 | $5,907 |
| 2011 | $3,488 |
| 2010 | $3,527 |
| 2009 | $3,651 |
| Agilent Technologies Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-04-30 | $7,950 |
| 2025-01-31 | $7,807 |
| 2024-10-31 | $7,887 |
| 2024-07-31 | $6,740 |
| 2024-04-30 | $6,653 |
| 2024-01-31 | $6,610 |
| 2023-10-31 | $6,577 |
| 2023-07-31 | $6,645 |
| 2023-04-30 | $6,843 |
| 2023-01-31 | $6,841 |
| 2022-10-31 | $6,754 |
| 2022-07-31 | $6,794 |
| 2022-04-30 | $6,812 |
| 2022-01-31 | $6,853 |
| 2021-10-31 | $6,906 |
| 2021-07-31 | $6,859 |
| 2021-04-30 | $6,884 |
| 2021-01-31 | $6,191 |
| 2020-10-31 | $6,212 |
| 2020-07-31 | $6,301 |
| 2020-04-30 | $6,284 |
| 2020-01-31 | $6,399 |
| 2019-10-31 | $6,263 |
| 2019-07-31 | $5,168 |
| 2019-04-30 | $5,210 |
| 2019-01-31 | $5,240 |
| 2018-10-31 | $4,693 |
| 2018-07-31 | $4,682 |
| 2018-04-30 | $4,259 |
| 2018-01-31 | $4,301 |
| 2017-10-31 | $4,257 |
| 2017-07-31 | $4,265 |
| 2017-04-30 | $4,216 |
| 2017-01-31 | $4,237 |
| 2016-10-31 | $4,159 |
| 2016-07-31 | $4,204 |
| 2016-04-30 | $4,152 |
| 2016-01-31 | $3,903 |
| 2015-10-31 | $3,793 |
| 2015-07-31 | $3,773 |
| 2015-04-30 | $3,792 |
| 2015-01-31 | $3,865 |
| 2014-10-31 | $5,306 |
| 2014-07-31 | $5,546 |
| 2014-04-30 | $5,649 |
| 2014-01-31 | $5,565 |
| 2013-10-31 | $5,703 |
| 2013-07-31 | $5,694 |
| 2013-04-30 | $5,769 |
| 2013-01-31 | $5,941 |
| 2012-10-31 | $5,907 |
| 2012-07-31 | $5,546 |
| 2012-04-30 | $3,403 |
| 2012-01-31 | $3,384 |
| 2011-10-31 | $3,488 |
| 2011-07-31 | $3,530 |
| 2011-04-30 | $3,553 |
| 2011-01-31 | $3,446 |
| 2010-10-31 | $3,527 |
| 2010-07-31 | $3,365 |
| 2010-04-30 | $2,055 |
| 2010-01-31 | $2,055 |
| 2009-10-31 | $3,651 |
| 2009-07-31 | $3,676 |
| 2009-04-30 | $3,693 |
| 2009-01-31 | $4,154 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.278B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.741B | 26.94 |
| Boston Scientific (BSX) | United States | $155.895B | 37.18 |
| Stryker (SYK) | United States | $147.123B | 29.95 |
| EssilorLuxottica (ESLOY) | France | $145.891B | 0.00 |
| Medtronic (MDT) | Ireland | $116.772B | 16.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.160B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.031B | 25.15 |
| ResMed (RMD) | United States | $42.217B | 30.19 |
| GE HealthCare Technologies (GEHC) | United States | $33.398B | 15.70 |
| Terumo (TRUMY) | Japan | $27.302B | 32.35 |
| Koninklijke Philips (PHG) | Netherlands | $26.423B | 17.48 |
| Insulet (PODD) | United States | $23.078B | 77.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.685B | 13.17 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.192B | 0.00 |
| Baxter (BAX) | United States | $12.250B | 9.46 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.714B | 28.33 |
| Lantheus Holdings (LNTH) | United States | $4.023B | 10.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.400B | 23.79 |
| Perrigo (PRGO) | Ireland | $3.224B | 8.05 |
| Prestige Consumer Healthcare (PBH) | United States | $3.221B | 14.29 |
| ICU Medical (ICUI) | United States | $3.005B | 20.46 |
| Haemonetics (HAE) | United States | $2.601B | 11.61 |
| LeMaitre Vascular (LMAT) | United States | $2.183B | 46.82 |
| Acuren (TIC) | United States | $2.054B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.918B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.804B | 77.48 |
| AtriCure (ATRC) | United States | $1.776B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.742B | 10.97 |
| Phibro Animal Health (PAHC) | United States | $1.279B | 16.35 |
| AdaptHealth (AHCO) | United States | $1.261B | 17.92 |
| Tilray Brands (TLRY) | Canada | $1.222B | 0.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| BioLife Solutions (BLFS) | United States | $1.201B | 2508.00 |
| Valneva SE (VALN) | France | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 8.31 |
| Kestra Medical Technologies (KMTS) | United States | $0.876B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.622B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.609B | 0.00 |
| SNDL (SNDL) | Canada | $0.589B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.587B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.58 |
| Surmodics (SRDX) | United States | $0.516B | 0.00 |
| Evolus (EOLS) | United States | $0.480B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.471B | 16.20 |
| CeriBell (CBLL) | United States | $0.428B | 0.00 |
| Owens & Minor (OMI) | United States | $0.392B | 3.48 |
| Sanuwave Health (SNWV) | United States | $0.354B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Omeros (OMER) | United States | $0.305B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.297B | 0.00 |
| Brainsway (BWAY) | Israel | $0.283B | 57.65 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| High Tide (HITI) | Canada | $0.273B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.270B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.231B | 0.00 |
| Cerus (CERS) | United States | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| Exagen (XGN) | United States | $0.220B | 0.00 |
| Organigram Global (OGI) | Canada | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.37 |
| FitLife Brands (FTLF) | United States | $0.155B | 19.10 |
| Biote (BTMD) | United States | $0.149B | 4.95 |
| Jushi Holdings (JUSHF) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.17 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.084B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.054B | 31.47 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.50 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.82 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |